Cure My Disease

Don't miss your cure!

 Log in / Sign up

Tailored talk therapy may tame tough bulimia cases

NCT ID NCT00494858

Disease control Sponsor: Boston University Charles River Campus Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 20, 2026 · Last updated Jul 21, 2026 · Updated 1 time

Summary

This study tests two versions of cognitive behavioral therapy (CBT) for adult women with a specific form of bulimia nervosa that also involves borderline personality traits. One therapy focuses only on eating disorder symptoms, while the other also addresses mood and relationship issues. Over 20 sessions in 5 months, researchers will compare how well each approach reduces eating disorder symptoms, depression, anxiety, and improves relationships.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
cognitive behavioral therapy (two types: focused and broad)
What this could lead to
If successful, this could show which type of therapy works best for women with bulimia nervosa who also have borderline personality traits, leading to more personalized treatment.
What could go wrong
This is a small, early-stage study with only 50 participants, so results may not apply to everyone. The therapies require many sessions and may not work for all individuals.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

50 people

The number who actually took part.

Start date

Jul 2007

Finished

Dec 2012

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Diagnosis of bulimia nervosa * Presence of borderline personality disorder features * History of one mood or anxiety episode within 2 years prior to study entry * If taking psychiatric medication, dose has been stable for at least 6 weeks at time of study entry Exclusion Criteria: * Substance dependence * Diagnosis of bipolar I disorder * Psychosis * Mental retardation * Receiving psychosocial treatment

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Eating disorders are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

bulimia nervosa eating disorder Feeding and Eating Disorders Personality Disorders

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Eating disorders

Contacts and locations

Locations

  • Center for Anxiety and Related Disorders, Boston University

    Boston, Massachusetts, 02215, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.